Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers

被引:0
作者
Roza Ghotbi
Alvin Gomez
Lili Milani
Gunnel Tybring
Ann-Christine Syvänen
Leif Bertilsson
Magnus Ingelman-Sundberg
Eleni Aklillu
机构
[1] Karolinska University Hospital Huddinge,Division of Clinical Pharmacology, Department of Laboratory Medicine
[2] Karolinska Institutet,Department of Physiology and Pharmacology
[3] Section of Pharmacogenetics,Department of Medical Sciences
[4] Karolinska Institutet,undefined
[5] Molecular Medicine,undefined
[6] Uppsala University,undefined
来源
The Pharmacogenomics Journal | 2009年 / 9卷
关键词
CYP1A2; drug-metabolizing enzyme; gene expression; allele-specific expression; epigenetics; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
The basis for interindividual variation in the CYP1A2 gene expression is not fully understood and the known genetic polymorphisms in the gene provide no explanation. We investigated whether the CYP1A2 gene expression is regulated by DNA methylation and displays allele-specific expression (ASE) using 65 human livers. Forty-eight percent of the livers displayed ASE not associated to the CYP1A2 mRNA levels. The extent of DNA methylation of a CpG island including 17 CpG sites, close to the translation start site, inversely correlated with hepatic CYP1A2 mRNA levels (P=0.018). The methylation of two separate core CpG sites was strongly associated with the CYP1A2 mRNA levels (P=0.005) and ASE phenotype (P=0.01), respectively. The CYP1A2 expression in hepatoma B16A2 cells was strongly induced by treatment with 5-aza-2′-deoxycytidine. In conclusion, the CYP1A2 gene expression is influenced by the extent of DNA methylation and displays ASE, mechanisms contributing to the large interindividual differences in CYP1A2 gene expression.
引用
收藏
页码:208 / 217
页数:9
相关论文
共 227 条
[1]  
Shimada T(1994)Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 414-423
[2]  
Yamazaki H(1994)Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test Br J Clin Pharmacol 38 471-473
[3]  
Mimura M(1993)Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2 J Pharmacol Exp Ther 265 401-407
[4]  
Inui Y(1993)Identification of P450 enzymes involved in metabolism of verapamil in humans Naunyn Schmiedebergs Arch Pharmacol 348 332-337
[5]  
Guengerich FP(2001)Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity Clin Pharmacol Ther 70 10-16
[6]  
Bertilsson L(1998): a pilot study Chem Res Toxicol 11 659-665
[7]  
Carrillo JA(1990)Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes Cancer Res 50 3367-3376
[8]  
Dahl ML(1995)Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450 Pharmacogenetics 5 259-274
[9]  
Llerena A(1993)Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity Pharmacogenetics 3 239-249
[10]  
Alm C(2001)Expression of CYP1A1 and CYP1A2 genes in human liver Arch Biochem Biophys 393 308-315